Outcome | Number of studies | Odds Ratio (95% CI) | Heterogeneity | |
---|---|---|---|---|
Chi2 p-value | I2 (%) | |||
All Contraceptive method use | 12 | 1.73 (1.51–1.98) | 0.00001 | 83 |
Total unmet need | 3 | 0.86 (0.78–0.94) | 0.14 | 50 |
Current use of | ||||
Pills* | 11 | 1.38 (1.06–1.79) | 0.00001 | 75 |
Condom* | 11 | 1.32 (1.0, 1.77) | 0.00001 | 93 |
Injectable | 8 | 0.92 (0.67–1.27) | 0.00001 | 88 |
Male sterilization | 4 | 1.22 (0.73–2.05) | 0.16 | 37 |
Female Sterilization | 9 | 0.91 (0.71–1.15) | 0.001 | 82 |
Intra-Uterine Device* | 11 | 1.62 (1.05–2.50) | 0.001 | 91 |
Implants | 4 | 1.76 (0.86–3.61) | 0.11 | 44 |
Knowledge | ||||
Condom* | 7 | 2.03 (1.19–3.47) | 0.001 | 98 |
Pills | 8 | 1.45 (1.01–2.08) | 0.001 | 95 |
Injectable | 6 | 1.55 (1.03–2.33) | 0.001 | 97 |
Male sterilization | 6 | 1.63 (0.81–3.29) | 0.001 | 99 |
Female Sterilization | 6 | 1.59 (1.03, 2.45) | 0.001 | 97 |
Intra-Uterine Device | 6 | 1.53 (0.79–2.95) | 0.001 | 99 |
Implants | 3 | 2.86 (1.16–7.06) | 0.001 | 97 |
ECP use | 3 | 1.31 (0.65–2.67) | 0.001 | 91 |